Bromide

Bromide

SCHEMBL5140665

Br.Cc1ccc2nc(CN(Cc3ccc(CNCc4ccccn4)cc3)C3CCCc4cccnc43)oc2c1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 20/20 0.62
CYP3A4 P08684 8/20 0.56
CYP2D6 P10635 8/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4063733 0.99 CXCR4 (0.63) CXCR4CYP3A4CYP2D6
Bromide SCHEMBL5140019 0.91 CXCR4 (0.69) CXCR4CYP3A4CYP2D6
SCHEMBL4064711 0.90 CXCR4 (0.70) CXCR4CYP3A4CYP2D6
SCHEMBL4065897 0.83 CXCR4 (0.44) CXCR4CYP3A4CYP2D6
Bromide SCHEMBL4541387 0.82 CXCR4 (0.75) CXCR4CYP3A4CYP2D6
Bromide SCHEMBL4550505 0.82 CXCR4 (0.75) CXCR4CYP3A4CYP2D6
SCHEMBL1875171 0.81 CXCR4 (0.76) CXCR4CYP3A4CYP2D6
SCHEMBL29823490 0.81 CXCR4 (0.76) CXCR4CYP3A4CYP2D6
SCHEMBL29823322 0.81 CXCR4 (0.76) CXCR4CYP3A4CYP2D6
SCHEMBL1877199 0.81 CXCR4 (0.76) CXCR4CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396840-B2 Chemokine receptor binding heterocyclic compounds GENZYME CORPORATION (US) 2008-07-08 US disclosed